KEMIFARMA Consulting ApS: Financial statements 2014
CVR: 34709955
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -10,291 and a net result of DKK 296,034 compared with DKK 18,794 the year before. Equity in the 2014 report amounted to DKK 1,973,440. The solvency ratio was 97.2%.
- Gross Profit
- DKK -10,291
- Profit/Loss
- DKK 296,034
- Equity
- DKK 1,973,440
- Total Assets
- DKK 2,030,020
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -10K | 296K | 2M | - |
| 2013 | - | -15K | 19K | 1.8M | - |
| 2012 | - | -8K | 449K | 1.8M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
KEMIFARMA Consulting ApS has published its annual report for 2013. Gross profit came to DKK -14,804, and the net result was DKK 18,794.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.